ARVINAS, INC.
ARVN · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Smaldone Alsup Laurie: Form 4
Insider disclosure · Filed · Report period 24 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ARVN · 04335A105 - Common stock, par value $0.001 per share
Company details and SEC sources
CIK 0001655759 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ARVN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 395 Winchester Ave, 5 Science Park, New Haven, CT, 06511
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- ARVINAS HOLDING COMPANY, LLC (to 28 Sep 2018)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields